A doctor holds a Regeneron monoclonal antibody infusion bag during a news conference Thursday, Aug. 19, 2021 at a hospital in Fort Lauderdale, Fla. (Joe Cavaretta/South Florida Sun-Sentinel via AP, File)
January 27, 2022
Stories this photo appears in:
January 26, 2022 5 p.m.
FDA halts use of antibody drugs that don't work vs. omicron
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.